ARTICLE | Clinical News
Lefamulin: Ph III LEAP 1 ongoing
February 3, 2017 5:33 PM UTC
An independent committee recommended continuation of the double-blind, international Phase III LEAP 1 trial comparing IV and oral lefamulin vs. IV and oral moxifloxacin with or without Zyvox linezolid...
BCIQ Company Profiles
BCIQ Target Profiles